Portfolio Update

RNS Number : 5110F

Intl. Biotechnology Trust PLC

21 February 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 January 2018

Net Assets	£233m
Net Assets per share	619p
Share price	614p
Total value of unquoted investments	£20m
Total number of portfolio companies	92
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Biogen	6.2
Celgene	4.6
Nektar	4.4
Regeneron	4.0
Exelixis	3.8
Acadia	3.7
Vertex	3.6
Adamas	3.6
Genmab	3.1
Gilead	3.1
	-----------
Total	40.1

Geographical Allocation	% NAV
US & Canada	91
Europe & UK	9
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	92
Unquoted	8
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	40
Mid Cap =USD1-10BN	34
Small Cap <USD1BN	26
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	38
Rare diseases	14
CNS	14
Inflammation	8
Ophthalmology	6
Metabolic	5
Infectious Diseases	4
Medtech	2
Other	9
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

21 FEBRUARY 2018

 

END

 

 

PFUGCGDDLXDBGIB